<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03131466</url>
  </required_header>
  <id_info>
    <org_study_id>KY2017-004-01</org_study_id>
    <nct_id>NCT03131466</nct_id>
  </id_info>
  <brief_title>High-voltage Pulsed Radiofrequency on Gasserian Ganglion to Treat Patients With Primary Trigeminal Neuralgia</brief_title>
  <official_title>Effectiveness and Safety of High-voltage Pulsed Radiofrequency on Gasserian Ganglion to Treat Patients With Primary Trigeminal Neuralgia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Ditan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed to compare the effectiveness and safety of high-voltage Pulsed
      radiofrequency and nerve block for the treatment of primary Trigeminal Neuralgia patients
      with ineffective conservative treatment and explore better non-surgical treatment methods for
      Trigeminal Neuralgia patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Trigeminal neuralgia (TN) is a paroxysmal, lightning-like, severe pain in the facial area
      innervated by trigeminal nerve. Patients who have failed to achieve benefits from drug
      treatment could try to undergo nerve block, a traditional conservative treatment. Pulsed
      radiofrequency (PRF) is a noninvasive pain intervention technique for the treatment of TN.
      However, its treatment effectiveness has rarely been reported and remains controversial among
      scholars. A recent single-center preliminary clinical study showed that high-voltage PRF had
      significant effectiveness in the treatment of TN. However, whether high-voltage PRF treatment
      can become an optional treatment for TN patients who have failed to achieve benefits from
      drug treatment still needs to be confirmed with standardized clinical studies by utilizing
      conservative nerve block treatment as a control. The study is designed to compare the
      effectiveness and safety of high-voltage PRF and nerve block for the treatment of primary TN
      patients with ineffective conservative treatment and explore better non-surgical treatment
      methods for TN patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 28, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effective rate of Primary Trigeminal Neuralgia treatment</measure>
    <time_frame>1 year after operation</time_frame>
    <description>The Barrow Neurological Institute (BNI) pain intensity score will be used to assess pain degree. Pain relief degree will be evaluated as &quot;excellent&quot; (BNI pain score I-II), &quot;good&quot; (BNI pain score III), and &quot;poor&quot; (BNI pain score IV-V). The effective rate=excellent and good pain relief (BNI I - III)/total number of cases * 100%.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>1 day, 1 week, 2 weeks, 1 month, 3 months, 6 months and 1 year after operation</time_frame>
    <description>Patient satisfaction score (PSS) score will be used to evaluate patient satisfaction: 0 point indicates unsatisfactory, while 10 points indicates very satisfactory.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dosage of adjuvant antiepileptic drugs</measure>
    <time_frame>1 day, 1 week, 2 weeks, 1 month, 3 months, 6 months and 1 year after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Data regarding patients with a BNI of IV or V who switch to other treatments</measure>
    <time_frame>1 day, 1 week, 2 weeks, 1 month, 3 months, 6 months and 1 year after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>1 day, 1 week, 2 weeks, 1 month, 3 months, 6 months and 1 year after opeartion</time_frame>
    <description>Data regarding intraoperative and postoperative adverse events.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">134</enrollment>
  <condition>Idiopathic Trigeminal Neuralgia</condition>
  <arm_group>
    <arm_group_label>PRF Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group will undergo 42°C high-voltage pulsed radiofrequency treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nerve Block Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group will undergo nerve block treatment with steroid and local anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High-voltage pulsed radiofrequency</intervention_name>
    <description>The manual PRF mode of the pain treatment generator will be turned on, the upper temperature limit will be set at 42°C, the PRF output voltage will be gradually increased to the highest voltage the patient can tolerate, and the patient will be treated for 360 s. After the treatment, 1.4 ml of a mixture of 0.4 mL of normal saline and 1 mL of 1% plain lidocaine will be injected through the needle of the cannula, and before the needle being removed, 0.5 mL of normal saline will be injected.</description>
    <arm_group_label>PRF Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nerve block</intervention_name>
    <description>The radiofrequency generator will be set at the sensory stimulating mode, and the lowest frequency of 0.2 V will be used for 360s-sham PRF treatment, after which 1.4 mL of a mixture of 2 mg of dexamethasone sodium phosphate and 1 mL of 1% plain lidocaine will be slowly injected through the radiofrequency treatment cannula needle. Before the needle being removed, 0.5 mL of normal saline will be injected.</description>
    <arm_group_label>Nerve Block Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Primary Trigeminal Neuralgia meets the criteria of the International
             Classification of Headache Disorders.

          -  18-75 years old.

          -  Response to drug treatment poorly or unable to tolerate the side effects of drugs.

          -  A BNI pain intensity scale score of IV-V.

          -  Supposed to undergo neurosurgical intervention according to Trigeminal Neuralgia
             treatment guidelines.

          -  Agree to participate in this trial and have signed the informed consent.

        Exclusion Criteria:

          -  Abnormal routine blood, liver or kidney functions, abnormal blood biochemistry test,
             or coagulation disorders.

          -  Abnormal electrocardiogram or chest X-ray results.

          -  Severe cardiopulmonary dysfunction.

          -  Infection at the puncture site.

          -  History of mental illness, or history of narcotic drug abuse.

          -  Allergy to local anesthetic drugs or steroids.

          -  Cannot cooperate with the treatment.

          -  History of invasive treatments, such as radiofrequency thermocoagulation, chemical
             ablation, balloon compression surgery, gamma knife treatment, peripheral denervation
             or microvascular decompression.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fang Luo, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tiantan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fang Luo, M.D.</last_name>
    <phone>+86 13611326978</phone>
    <email>13611326978@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Ditan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100015</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hao Cheng, M.D.</last_name>
      <phone>+86 13801312117</phone>
      <email>chenghaocn@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Hao Cheng, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanping Li, M.D.</last_name>
      <phone>+86 13701197818</phone>
      <email>yanping7391@sina.com</email>
    </contact>
    <investigator>
      <last_name>Yanping Li, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Tiantan Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fang Luo, M.D.</last_name>
      <phone>+86 13611326978</phone>
      <email>13211326978@163.com</email>
    </contact>
    <investigator>
      <last_name>Fang Luo, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Nader A, Kendall MC, De Oliveria GS, Chen JQ, Vanderby B, Rosenow JM, Bendok BR. Ultrasound-guided trigeminal nerve block via the pterygopalatine fossa: an effective treatment for trigeminal neuralgia and atypical facial pain. Pain Physician. 2013 Sep-Oct;16(5):E537-45.</citation>
    <PMID>24077204</PMID>
  </reference>
  <reference>
    <citation>Nader A, Bendok BR, Prine JJ, Kendall MC. Ultrasound-Guided Pulsed Radiofrequency Application via the Pterygopalatine Fossa: A Practical Approach to Treat Refractory Trigeminal Neuralgia. Pain Physician. 2015 May-Jun;18(3):E411-5.</citation>
    <PMID>26000688</PMID>
  </reference>
  <reference>
    <citation>Elsheikh NA, Amr YM. Calcitonin as an Additive to Local Anesthetic and Steroid Injection Using a Modified Coronoid Approach in Trigeminal Neuralgia. Pain Physician. 2016 Sep-Oct;19(7):457-64.</citation>
    <PMID>27676662</PMID>
  </reference>
  <reference>
    <citation>Tsou HK, Chao SC, Wang CJ, Chen HT, Shen CC, Lee HT, Tsuei YS. Percutaneous pulsed radiofrequency applied to the L-2 dorsal root ganglion for treatment of chronic low-back pain: 3-year experience. J Neurosurg Spine. 2010 Feb;12(2):190-6. doi: 10.3171/2009.9.SPINE08946.</citation>
    <PMID>20121355</PMID>
  </reference>
  <reference>
    <citation>Fang L, Ying S, Tao W, Lan M, Xiaotong Y, Nan J. 3D CT-guided pulsed radiofrequency treatment for trigeminal neuralgia. Pain Pract. 2014 Jan;14(1):16-21. doi: 10.1111/papr.12041. Epub 2013 Feb 21.</citation>
    <PMID>23433058</PMID>
  </reference>
  <reference>
    <citation>Luo F, Meng L, Wang T, Yu X, Shen Y, Ji N. Pulsed radiofrequency treatment for idiopathic trigeminal neuralgia: a retrospective analysis of the causes for ineffective pain relief. Eur J Pain. 2013 Sep;17(8):1189-92. doi: 10.1002/j.1532-2149.2012.00278.x. Epub 2013 Jan 16.</citation>
    <PMID>23322665</PMID>
  </reference>
  <reference>
    <citation>Fang L, Tao W, Jingjing L, Nan J. Comparison of High-voltage- with Standard-voltage Pulsed Radiofrequency of Gasserian Ganglion in the Treatment of Idiopathic Trigeminal Neuralgia. Pain Pract. 2015 Sep;15(7):595-603. doi: 10.1111/papr.12227. Epub 2014 Jun 23.</citation>
    <PMID>24954016</PMID>
  </reference>
  <reference>
    <citation>Maarbjerg S, Di Stefano G, Bendtsen L, Cruccu G. Trigeminal neuralgia - diagnosis and treatment. Cephalalgia. 2017 Jun;37(7):648-657. doi: 10.1177/0333102416687280. Epub 2017 Jan 11. Review.</citation>
    <PMID>28076964</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2017</study_first_submitted>
  <study_first_submitted_qc>April 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2017</study_first_posted>
  <last_update_submitted>June 12, 2017</last_update_submitted>
  <last_update_submitted_qc>June 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Fang Luo</investigator_full_name>
    <investigator_title>vice director of Department of Anesthesiology and Pain Management</investigator_title>
  </responsible_party>
  <keyword>Trigeminal Neuralgia</keyword>
  <keyword>Pulsed Radiofrequency</keyword>
  <keyword>Gasserian Ganglion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Ganglion Cysts</mesh_term>
    <mesh_term>Trigeminal Neuralgia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

